alternatives to glp 1 agonists Targeting GLP-1, GIP & GCG in Obesity and Type 2 Diabetes Research Weight Loss Medication Alternatives To
Description
Lixisenatide Lixisenatide was developed by Sanofi-Aventis in France
The inclusion of chromium picolinate aids in maintaining regular blood glucose management, helping to prevent energy crashes and unnecessary cravings throughout the day
The anti-inflammatory properties significantly aid in the therapy of metabolic syndrome
Weight loss was more pronounced in patients with a BMI over 35, compared to those under 35
The highest studied dose showed major weight loss over 80 weeks
rskov, C., Holst, J
